1245932

David J. Wyatt, M.D. — FEI 3020417653

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 8, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical BA/BE